From molecules to the capital markets.

Dr George Syrmalis is an M.D, Ph.D qualified physician, scientist, and venture capitalist whose career spans nuclear medicine, radiation immunology, and the global life-sciences capital markets. As the Founder and Chief Executive Officer of Bioscience Equity Partners, he has dedicated his work to transforming bioscience innovation into sustainable, investable enterprises. Over three decades, he has founded and guided multiple biotechnology companies from discovery to public listing, and today focuses on providing venture capital to early stage biotechs and med-tech ventures globally. His writing examines the convergence of science, markets, and human progress.